...
首页> 外文期刊>Journal of Virological Methods >Inhibition of replication of classical swine fever virus in a stable cell line by the viral capsid and Staphylococcus aureus nuclease fusion protein
【24h】

Inhibition of replication of classical swine fever virus in a stable cell line by the viral capsid and Staphylococcus aureus nuclease fusion protein

机译:病毒衣壳和金黄色葡萄球菌核酸酶融合蛋白抑制经典猪瘟病毒在稳定细胞系中的复制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Classical swine fever (CSF) is one of the major diseases causing serious economic losses to the swine industry. To explore the feasibility of using capsid-targeted viral inactivation (CTVI) as an antiviral strategy against CSF infection, a plasmid pcDNA-Cap-SNase was constructed for expressing a fusion protein of CSFV capsid (Cap) and Staphylococcus aureus nuclease (SNase). Under G418 selection, a mammalian cell line PK-15 expressing stably the fusion protein Cap-SNase(PK-15/Cap-SNase)could be detected by rabbit antiserum against CSFV capsid protein and had good nuclease activity in cleaving linearized plasmid DNA. The CSFV titer produced from infection of this PK-15/Cap-SNase stable cell line was reduced by an order of 10(2)-10(33) or 70.8% compared to that produced in control PK-15 cells. Detection of the virus by ELISA indicated that CSFV propagation was inhibited in the PK-15/Cap-SNase cell line. It was demonstrated clearly that the fusion protein Cap-SNase could inhibit effectively the production of CSFV, resulting in a reduction in infectious titers. Therefore, CTVI may be valuable therapeutic approach against CSFV. Crown Copyright (C) 2010 Published by Elsevier B.V. All rights reserved.
机译:古典猪瘟(CSF)是引起猪业严重经济损失的主要疾病之一。为了探索将衣壳靶向的病毒灭活(CTVI)作为抗CSF感染的抗病毒策略的可行性,构建了质粒pcDNA-Cap-SNase,用于表达CSFV衣壳(Cap)和金黄色葡萄球菌核酸酶(SNase)的融合蛋白。在G418选择下,可以通过兔抗CSFV衣壳蛋白的血清检测到稳定表达融合蛋白Cap-SNase(PK-15 / Cap-SNase)的哺乳动物细胞系PK-15,并具有良好的核酸酶切割线性质粒DNA的活性。与对照PK-15细胞相比,此PK-15 / Cap-SNase稳定细胞系感染产生的CSFV滴度降低了10(2)-10(33)或70.8%。通过ELISA检测病毒表明CSFV在PK-15 / Cap-SNase细胞系中的繁殖受到抑制。清楚地表明,融合蛋白Cap-SNase可以有效抑制CSFV的产生,导致感染滴度的降低。因此,CTVI可能是针对CSFV的有价值的治疗方法。官方版权(C)2010,Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号